v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (4,271,846) $ (1,578,406) $ (2,160,998) $ (48,319,475)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation expense 3,155 3,155 711,929
Loss on sale of investment in preferred securities 340,408    
Amortization of contract asset 387,216 129,072
Discount on common stock sold pursuant to the ELOC 210,109    
Stock compensation expense 141,954 1,379,880 1,523,489 1,575,952
Gain on extinguishment of forward purchase derivative (3,308,713) (3,336,213)
Amortization of prepaid consulting from the issuance of Series B Convertible Preferred Stock and Series B Warrants     59,857
Amortization of prepaid consulting (Series B Preferred Stock) 108,891    
Amortization of internally generated software 4,198    
Net deferred indemnified loan origination fees     (63,275)
Discount on common stock sold pursuant to the ELOC     76,553
Costs incurred to secure financing 800,000 800,000
Shares issued in settlement of a legal dispute 200,000 200,000
Debt discount 137,500 137,500
Lease expense (16,556) (4,150) (7,981) 23,181
Credit loss (benefit) expense     (177,917) (1,393,131)
Impairment of goodwill     6,058,000
Impairment of long-lived intangible assets     3,090,881
Deferred tax expense, net     43,859,686
Marketing expense settled via Common Stock     100,000
Change in fair value of warrant and forward purchase option derivative liabilities (39,322) (596,823) (1,320,871) (2,803,638)
Change in the fair value of deferred consideration (79,475) (79,475) (361,449)
Credit benefit (1,056,107)    
Gain on extinguishment of debt (27,500)    
Changes in operating assets and liabilities:        
Accounts receivable – trade 13,442 88,376 103,233 (12,734)
Accounts receivable – related party 254,961 302,880 (41,460) 1,127,297
Prepaid expenses 13,039 524,571 561,913 86,901
Other current liabilities (268,633) (34,351) (48,960) 527
Accrued interest receivable 16,319 16,319 (2,542)
Other current assets (206,256) 4,057 (2,968,061)
Accounts payable 162,477 628,609 49,105 (76,672)
Accounts payable – related party 2,801 101,458 95,757 (501,709)
Accrued expenses (18,322) (697,326) 9,085 292,396
Contract liabilities (3,123)    
Other assets (4,034)    
Deferred revenue (11,666) (12,920) 6,413
Net cash used in operating activities (4,046,990) (2,353,375) (3,417,700) 430,477
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:        
Proceeds from sale of investment preferred securities 786,154 50,000
Capitalized software development costs (251,904)    
Proceeds from loan sale 392,186 392,186 12,394
Net cash provided by investing activities 534,250 392,186 442,186 12,394
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:        
Tax withholding payments on vesting of restricted stock units     (12,771)
Proceeds from convertible debt 550,000 550,000
Redemption of Series B Convertible Preferred Stock     (292,800)
Issuance of Series B Convertible Preferred Stock, net of expenses 216,800 6,130,000
Offering cost     (351,646)
Proceeds from the sale of Class A Common Stock     1,778,987
Repayment of financed insurance contract     (116,098)
Net share settlement for stock compensation expense (12,771)    
Proceeds from the sale of common stock pursuant to the ELOC 1,129,769    
Repayment of senior secured promissory note (255,765) (255,765) (3,006,993)
Net cash provided by (used in) financing activities 1,129,769 498,264 7,429,907 (3,006,993)
Net decrease in cash and cash equivalents (2,382,971) (1,462,925) 4,454,393 (2,564,122)
Cash and cash equivalents – beginning of period 6,779,040 2,324,647 2,324,647 4,888,769
Cash and cash equivalents – end of period 4,396,069 861,722 6,779,040 2,324,647
SUPPLEMENTAL CASH FLOW INFORMATION:        
Interest paid 6,870 344,041 388,457 416,852
Supplemental noncash investing and financing activities:        
Reclassification of forward purchase receivable (4,584,221) (4,584,221)
Accrued redemption payable to Series B holders 295,023    
Receivable for unsettled ADTX sale 323,438    
Marketing expense settled by the issuance of Common Stock     50,000
Investment in Preferred Securities 1,500,000 1,500,000
Prepaid consulting expense from the issuance of the Series B Convertible Preferred Stock and Series B Warrants     371,307
Extinguishment of debt for issuance of Series B Convertible Preferred Stock and Series B Warrants     10,748,408
Exchange of forward purchase derivative liability for the issuance of Series B Convertible Preferred Stock and Series B Warrants     4,000,867
Exchange of convertible notes for Series B Convertible Preferred stock and Series B warrants 825,000 659,997
Financed insurance contract (classified in accrued expense)     395,900
Shares issued in settlement of a legal dispute 200,000 258,868
Accrued redemption payable to Series B holders     181,378
ELOC proceeds receivable 1,362    
Prepaid Consulting Contracts 318,557    
Extinguishment of debt for equity 10,748,409    
Equity issued to settle forward purchase derivative liability, 7,309,580    
Recognition of contract asset with corresponding stand-ready guarantee liability     2,135,000
Recognition of contract asset with corresponding financial indemnification liability     $ 1,091,772
Offering costs, associated with issuance of Series B Convertible Preferred Stocks and Series B Warrants 427,087    
Forfeiture of Series B shares related to consulting contract 72,148    
Proceeds from the issuance of Series B Convertible Preferred Stock and Series B Warrants $ 5,913,200